The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.
Advertisement
The Scientist
Most Recent
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Officials in the most populous nation on Earth have finally owned up to clusters of the disease around areas beset by industrial waste and other pollutants.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Why so few scientists make the leap to policy-making positions, and why more should give it a try
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Meet the bacterium that pulls gold ions out of solution and forms tiny nuggets of the precious metal.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
After a 4-year stretch as US Energy Secretary, during which he fought to fund research on clean energy technology, Steven Chu has announced his resignation.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
